FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 99 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q1 2022. The put-call ratio across all filers is 6.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $324,000 | -39.2% | 16,218 | -71.7% | 0.01% | -40.0% |
Q1 2022 | $533,000 | -34.5% | 57,275 | 0.0% | 0.01% | -52.4% |
Q4 2021 | $814,000 | -6.8% | 57,275 | +52.1% | 0.02% | +31.2% |
Q3 2021 | $873,000 | +167.0% | 37,647 | +186.2% | 0.02% | +166.7% |
Q2 2021 | $327,000 | +39.7% | 13,155 | +96.5% | 0.01% | +50.0% |
Q4 2020 | $234,000 | -79.9% | 6,695 | -71.3% | 0.00% | -88.6% |
Q3 2020 | $1,164,000 | – | 23,357 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EDBI Pte Ltd | 1,268,805 | $18,042,000 | 9.80% |
Samsara BioCapital, LLC | 1,565,526 | $22,262,000 | 4.32% |
Cormorant Asset Management, LP | 4,639,995 | $65,981,000 | 3.92% |
Logos Global Management LP | 1,600,000 | $22,752,000 | 2.35% |
RA Capital Management | 9,011,651 | $128,146,000 | 2.26% |
HighVista Strategies LLC | 40,612 | $578,000 | 0.46% |
ARMISTICE CAPITAL, LLC | 1,856,000 | $26,392,000 | 0.43% |
Artal Group S.A. | 1,000,000 | $14,220,000 | 0.39% |
Parkman Healthcare Partners LLC | 100,000 | $1,422,000 | 0.31% |
Integral Health Asset Management, LLC | 75,000 | $1,067,000 | 0.30% |